Pruritic papular eruption of HIV: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
==Background==
==Background==
*Most common rash of HIV
*Most common rash of HIV<ref>Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. Zancanaro PC et al. J Am Acad Dermatol. 2006 Apr;54(4):581-8.</ref>
*Presenting symptom of HIV in up to ~80% cases
*Presenting symptom of HIV in up to ~80% cases
*3x more common when CD4 count < 200
*3x more common when CD4 count < 200
Line 31: Line 31:
*Average time for recurrence of skin condition ~8 wks
*Average time for recurrence of skin condition ~8 wks


==Sources==
==References==
*Tallon B. Pruritic papular eruption of HIV. DermNet NZ. http://www.dermnetnz.org/viral/papulopruritic-hiv.html.
<references/>
*Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. Zancanaro PC et al. J Am Acad Dermatol. 2006 Apr;54(4):581-8.
*Schwartz RA et al. Cutaneous Manifestations of HIV. eMedicine. Updated Apr 27, 2015. http://emedicine.medscape.com/article/1133746-overview#showall.


[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:ID]]
[[Category:ID]]

Revision as of 23:59, 2 May 2016

Background

  • Most common rash of HIV[1]
  • Presenting symptom of HIV in up to ~80% cases
  • 3x more common when CD4 count < 200
  • Up to 46% of HIV pts have this rash at some time of disease course
  • Diagnosis of exclusion

Clinical Features

  • Pruritic
  • Diffusely, symmetrically distributed rash
  • Discrete red bumps initially
  • Extremities/trunk > face
  • Mucous membrane sparing

Differential

Treatments

  • Initially topical steroids, emollients, PO antihistamines
  • UV phototherapy for refractory cases

Disposition

  • Outpatient dermatology f/u
  • Average time for recurrence of skin condition ~8 wks

References

  1. Cutaneous manifestations of HIV in the era of highly active antiretroviral therapy: an institutional urban clinic experience. Zancanaro PC et al. J Am Acad Dermatol. 2006 Apr;54(4):581-8.